Natural Capsules Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter
- September 17, 2026
- Posted by: Harsh Piplani
- Category: Results
Natural Capsules share price Rs 175.00 on 17 September 2026, up 1.43%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 5.75 crore loss. Q2 FY26 base a loss of Rs 6.99 crore.
Quick Answer
The Natural Capsules Q2 results date for FY27 is not confirmed, and Natural Capsules Ltd. had not filed a board meeting intimation with the NSE or BSE as of 17 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 45.80 crore in revenue and a loss of Rs 6.99 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.
The Natural Capsules Q2 results FY27 announcement is the next scheduled earnings event for Natural Capsules Ltd., Natural Capsules manufactures empty hard gelatin and vegetarian capsules supplied to pharmaceutical and nutraceutical companies.. The stock traded at Rs 175.00 on the NSE on 17 September 2026, up 1.43% from the previous close of Rs 172.54, about 40.9% below its 52-week high of Rs 296.00 and 28.3% above its 52-week low of Rs 136.36.
What makes the Natural Capsules Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 45.80 crore of revenue and a loss of Rs 6.99 crore, while the most recent quarter on record, Q1 FY27, produced Rs 48.71 crore and a loss of Rs 5.75 crore. Everything below is built from those reported figures rather than from any forecast.
Click Here – Get Free Investment Predictions
When Is the Natural Capsules Q2 Results FY27 Date?
The Natural Capsules Q2 results date for FY27 is not confirmed. As of 17 September 2026, Natural Capsules Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.
What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Natural Capsules Q2 results date becomes public through that filing rather than through any advance announcement.
The Natural Capsules Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Natural Capsules.
Natural Capsules Q2 Results Expectations: What the Market Is Actually Tracking
No verified analyst estimate for the Natural Capsules Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Natural Capsules. The Natural Capsules Q2 results watchlist below is built from what the company has actually reported and disclosed.
Natural Capsules Q2 results will be reported for the September 2026 quarter against a backdrop of sustained losses. The company has posted a net loss in every one of the last five quarters, from Rs 5.58 crore in Jun25 to Rs 5.75 crore in Jun26, even as revenue has ranged between roughly Rs 38 crore and Rs 58 crore per quarter. This loss-making run is the central fact shaping how the Natural Capsules Q2 results should be read.
Operating profit itself turned negative in Sep25 and Dec25, with operating margin as low as -6.15% in Dec25, before turning modestly positive again in Mar26 and Jun26. Even in the quarters where operating profit was positive, the company still posted a large net loss, which points to interest and depreciation costs, both roughly doubled year on year, outweighing thin operating income. This is a currently loss-making company on the numbers reported so far, and that context carries directly into the Natural Capsules Q2 results.
Going into the September 2026 quarter, the key question for the Natural Capsules Q2 results is whether the modest operating profit seen in Mar26 and Jun26 can grow enough to offset high interest and depreciation charges. Return on equity and return on capital employed are both negative, and the price-to-earnings ratio is not meaningful given the trailing losses. These factors keep the Natural Capsules Q2 results firmly in loss-making territory for now, based on the historical trend.
Check Natural Capsules Ltd. Live Fundamentals on the Univest Screener
Natural Capsules Q2 Results Preview: The Q1 FY27 Actuals It Builds On
Natural Capsules Ltd. reported revenue of Rs 48.71 crore in Q1 FY27, up 7.77% from Rs 45.20 crore in Q1 FY26, and a loss of Rs 5.75 crore at the net level, a wider loss than the Rs 5.58 crore loss of Q1 FY26. These are reported actuals, not estimates.
Sequentially, revenue was down 16.66% over the March 2026 quarter figure of Rs 58.45 crore, and net profit was a wider loss than the Rs 4.98 crore loss of Q4 FY26. Operating margin stood at 0.71% in Q1 FY27 against negative 1.94% in the September 2025 quarter, which is the comparison the Natural Capsules Q2 results print will be read against.
Q2 FY26 Base: The Comparison Natural Capsules Q2 Results FY27 Must Beat
Natural Capsules Ltd. reported revenue of Rs 45.80 crore and a loss of Rs 6.99 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Natural Capsules Q2 results preview.
Because the base quarter itself was loss-making, a year-on-year percentage comparison of profit is not meaningful for Natural Capsules. The more useful test in the Natural Capsules Q2 results print is whether the company reports a profit at all, and how the income line of Rs 45.80 crore compares with the Rs 48.71 crore of the June 2026 quarter.
Natural Capsules Quarterly Results Trend Over the Last Four Quarters
| Quarter | Revenue (Rs Cr) | Net Profit (Rs Cr) |
|---|---|---|
| Q2 FY26 (Sep 2025) | 45.80 | (6.99) |
| Q3 FY26 (Dec 2025) | 37.75 | (7.12) |
| Q4 FY26 (Mar 2026) | 58.45 | (4.98) |
| Q1 FY27 (Jun 2026) | 48.71 | (5.75) |
Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company’s exchange filings, and they are the only basis this Natural Capsules Q2 results preview uses.
Revenue across those four quarters ranged from Rs 37.75 crore to Rs 58.45 crore, and net profit from Rs 7.12 crore loss to Rs 4.98 crore loss. That spread is the honest context for the Natural Capsules Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.
Key Factors That Could Shape Natural Capsules Q2 Results FY27
The Natural Capsules Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Natural Capsules has already reported.
Losses in Every Recent Quarter
Natural Capsules has reported a net loss in each of the last five quarters, from Jun25 through Jun26, with losses ranging from about Rs 4.98 crore to Rs 7.12 crore. This is a plain, sustained pattern rather than an isolated event, and it is the most important fact for anyone following the Natural Capsules Q2 results.
Operating Profit Turned Negative in Two Quarters
Operating margin fell to -1.94% in Sep25 and -6.15% in Dec25, meaning the core manufacturing business itself was unprofitable in those quarters, before recovering to a small positive 2.28-2.30% in Mar26 and Jun26. Even that recovery has not been enough to offset other costs, keeping net profit negative and shaping the tone of the Natural Capsules Q2 results.
Higher Interest and Depreciation Costs Weigh on the Bottom Line
Interest and depreciation costs have roughly doubled year on year, consistent with debt-funded capital expenditure, and are the main reason net losses have persisted even when operating profit turned positive. Return on equity (-9.45%) and return on capital employed (-4.58%) are both negative, underscoring that this remains a loss-making company heading into the Natural Capsules Q2 results.
Natural Capsules Q2 Results FY27: Share Price and Valuation Going Into the Print
Natural Capsules share price today is Rs 175.00 on the NSE, up Rs 2.46 or 1.43% from the previous close of Rs 172.54 on 17 September 2026, ahead of the Natural Capsules Q2 results announcement.
| Metric | Value (17 September 2026) |
|---|---|
| NSE Symbol | NATCAPSUQ |
| Current Market Price | Rs 175.00 |
| 52-Week High | Rs 296.00 |
| 52-Week Low | Rs 136.36 |
| Market Capitalisation | Rs 184 crore |
| PE Ratio | Not meaningful on a trailing loss |
| PB Ratio | 1.04 |
| EPS (TTM) | Not meaningful on a trailing loss |
| Book Value per Share | Rs 168.00 |
| Debt to Equity | 0.93 |
| Return on Equity | -9.45% |
| 50-Day Moving Average | Rs 165.32 |
| 200-Day Moving Average | Rs 163.51 |
| RSI (14) | 32.22 |
The stock trades above both its 50-day average of Rs 165.32 and its 200-day average of Rs 163.51, with a 14-day RSI of 32.22. None of this is a view on where the shares go once the Natural Capsules Q2 results are announced, and no price target is offered here.
Download the Univest iOS App or Univest Android App to track Natural Capsules Ltd. live price and quarterly earnings updates.
What Investors Should Watch When Natural Capsules Q2 Results Are Announced
Four lines carry most of the information in a company of this size, and reading them in order keeps the Natural Capsules Q2 results print in proportion.
- Revenue against the Rs 45.80 crore reported in the September 2025 base quarter
- Net profit against a loss of Rs 6.99 crore in that same quarter
- Operating margin against 0.71% in Q1 FY27
- Any exceptional item, provision or one-off gain disclosed alongside the numbers
A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Natural Capsules Q2 results announcement should be read together with the notes to the results rather than the headline alone.
Conclusion on Natural Capsules Q2 Results FY27
The Natural Capsules Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Natural Capsules Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.
On that basis the Natural Capsules Q2 results FY27 print faces a base of Rs 45.80 crore in revenue and a loss of Rs 6.99 crore, with the most recent quarter having delivered Rs 48.71 crore and a loss of Rs 5.75 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Natural Capsules, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Natural Capsules Q2 Results FY27
What is the Natural Capsules Q2 results date for FY27?
Ans. The Natural Capsules Q2 results date for FY27 is not confirmed. Natural Capsules Ltd. had not filed a board meeting intimation with the NSE or BSE as of 17 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.
What quarter do the Natural Capsules Q2 results 2026 cover?
Ans. The Natural Capsules Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Natural Capsules Ltd. reports revenue, operating profit and net profit for that period, and the Natural Capsules Q2 results filing also carries the notes to the accounts.
What were the Natural Capsules Q1 FY27 results?
Ans. Natural Capsules Ltd. reported revenue of Rs 48.71 crore in Q1 FY27 and a loss of Rs 5.75 crore at the net level. Revenue was up 7.77% versus Q1 FY26 and net profit was a wider loss than the Rs 5.58 crore loss of Q1 FY26.
What were Natural Capsules Q2 FY26 results in the September 2025 quarter?
Ans. Natural Capsules Ltd. reported revenue of Rs 45.80 crore and a loss of Rs 6.99 crore in Q2 FY26. Operating margin was negative 1.94%. Those figures form the base for the Natural Capsules Q2 results FY27 comparison.
What are the main Natural Capsules Q2 results expectations this quarter?
Ans. No verified analyst estimate is publicly available. The Natural Capsules Q2 results expectations centre on revenue against the Rs 45.80 crore base, net profit against a loss of Rs 6.99 crore, operating margin against 0.71% in Q1 FY27, and any exceptional item disclosed with the numbers.
What is Natural Capsules share price today ahead of the Q2 earnings?
Ans. Natural Capsules share price is Rs 175.00 on the NSE as of 17 September 2026, up 1.43% from Rs 172.54. The stock is about 40.9% below its 52-week high of Rs 296.00 and 28.3% above its 52-week low of Rs 136.36, at a market capitalisation of Rs 184 crore.
Is Natural Capsules a good stock to buy before the Q2 results?
Ans. This article does not offer a buy, sell or hold recommendation on Natural Capsules Ltd. The stock trades at a price-to-book ratio of 1.04 with a return on equity of -9.45%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.
